The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) protocol

Xun Tang, Yonghua Hu, Dafang Chen, Siyan Zhan, Zongxin Zhang, Huidong Dou, Xun Tang, Yonghua Hu, Dafang Chen, Siyan Zhan, Zongxin Zhang, Huidong Dou

Abstract

Background: The exact etiology of ischemic stroke remains unclear, because multiple genetic predispositions and environmental risk factors may be involved, and their interactions dictate the complexity. Family-based studies provide unique features in design, while they are currently underrepresented for studies of ischemic stroke in developing countries. The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) program aims to conduct a genetic pedigree study of ischemic stroke in rural communities of China.

Methods/design: The pedigrees of ischemic stroke with clear documentation are recruited by using the proband-initiated contact method, based on the stroke registry in hospital and communities. Blood samples and detailed information of pedigrees are collected through the health care network in the rural area, and prospective follow-up of the pedigrees cohort is scheduled. Complementary strategies of both family-based design and matched case-spousal control design are used, and comprehensive statistical methods will be implemented to ascertain potential complex genetic and environmental factors and their interactions as well.

Discussion: This study is complementary to other genetic pedigree studies of ischemic stroke, such as the Siblings With Ischemic Stroke Study (SWISS), which are established in developed countries. We describe the protocol of this family-based genetic epidemiological study that may be used as a new practical guideline and research paradigm in developing countries and facilitate initiatives of stroke study for international collaborations.

Figures

Figure 1
Figure 1
Geographic map of the Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) program region. The cross symbol and spots symbols in the map of Fangshan indicate the Central Hospital (the First Hospital of Fangshan District) and Community Register Sites respectively.
Figure 2
Figure 2
Flow chart for recruitment of ischemic stroke probands and their relative controls in FISSIC program. Abbreviations: FISSIC, the Fangshan/Family-based Ischemic Stroke Study In China; IS, ischemic stroke; QVSFS, the Questionnaire for Verifying Stroke-Free Status.

References

    1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182–187. doi: 10.1016/S1474-4422(07)70031-5.
    1. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456–464. doi: 10.1016/S1474-4422(07)70004-2.
    1. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. 2007;6:94–97. doi: 10.1016/S1474-4422(07)70007-8.
    1. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF. Proportion of different subtypes of stroke in China. Stroke. 2003;34:2091–2096. doi: 10.1161/01.STR.0000087149.42294.8C.
    1. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke. 2003;34:1364–1369. doi: 10.1161/01.STR.0000069723.17984.FD.
    1. Bak S, Gaist D, Sindrup SH, Skytthe A, Christensen K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke. 2002;33:769–774. doi: 10.1161/hs0302.103619.
    1. Carr FJ, McBride MW, Carswell HV, Graham D, Strahorn P, Clark JS, Charchar FJ, Dominiczak AF. Genetic aspects of stroke: human and experimental studies. J Cereb Blood Flow Metab. 2002;22:767–773. doi: 10.1097/00004647-200207000-00001.
    1. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007;6:149–161. doi: 10.1016/S1474-4422(07)70028-5.
    1. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, Jakobsson F, Einarsdottir E, Agnarsson U, Shkolny D, Einarsson G, Gudjonsdottir HM, Valdimarsson EM, et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet. 2002;70:593–603. doi: 10.1086/339252.
    1. Meschia JF, Brown RD, Jr, Brott TG, Chukwudelunzu FE, Hardy J, Rich SS. The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet. 2002;3:1. doi: 10.1186/1471-2350-3-1.
    1. Meschia JF, Kissela BM, Brott TG, Brown RD, Jr, Worrall BB, Beck J, Skarp AN. The Siblings With Ischemic Stroke Study (SWISS): a progress report. Clin Med Res. 2006;4:12–21.
    1. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol. 2004;61:1652–1661. doi: 10.1001/archneur.61.11.1652.
    1. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet. 2004;36:512–517. doi: 10.1038/ng1337.
    1. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet. 2006;7:385–394. doi: 10.1038/nrg1839.
    1. Barrett JH, Sheehan NA, Cox A, Worthington J, Cannings C, Teare MD. Family based studies and genetic epidemiology: theory and practice. Hum Hered. 2007;64:146–148. doi: 10.1159/000101993.
    1. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005;36:2027–2031. doi: 10.1161/01.STR.0000177498.21594.9e.
    1. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation. 2001;103:462–468.
    1. Jones WJ, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke. 2001;32:2232–2236.
    1. Meschia JF, Lojacono MA, Miller MJ, Brott TG, Atkinson EJ, O'Brien PC. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis. 2004;17:218–223. doi: 10.1159/000075794.
    1. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE., 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
    1. A haplotype map of the human genome. Nature. 2005;437:1299–1320. doi: 10.1038/nature04226.
    1. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol. 2002;155:478–484. doi: 10.1093/aje/155.5.478.
    1. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000;19:S36–42. doi: 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>;2-M.
    1. Martin ER, Bass MP, Hauser ER, Kaplan NL. Accounting for linkage in family-based tests of association with missing parental genotypes. Am J Hum Genet. 2003;73:1016–1026. doi: 10.1086/378779.
    1. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972;2:3–19. doi: 10.1007/BF01066731.
    1. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138–147. doi: 10.1086/321276.
    1. Worrall BB, Chen DT, Meschia JF. Ethical and methodological issues in pedigree stroke research. Stroke. 2001;32:1242–1249.
    1. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet. 2003;35:131–138. doi: 10.1038/ng1245.
    1. Dichgans M, Hegele RA. Update on the genetics of stroke and cerebrovascular disease 2006. Stroke. 2007;38:216–218. doi: 10.1161/01.STR.0000254710.32761.44.
    1. Wei G, Ji X, Bai H, Ding Y. Stroke research in China. Neurol Res. 2006;28:11–15. doi: 10.1179/016164106X91807.
    1. Nilsson-Ardnor S, Janunger T, Wiklund PG, Lackovic K, Nilsson AK, Lindgren P, Escher SA, Stegmayr B, Asplund K, Holmberg D. Genome-wide linkage scan of common stroke in families from northern Sweden. Stroke. 2007;38:34–40. doi: 10.1161/01.STR.0000251643.37454.16.
    1. Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, Lam TH, Pan WH, Rodgers A, Suh I, et al. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006;35:1412–1416. doi: 10.1093/ije/dyl222.
    1. Tang X, Zhu YP, Li N, Chen DF, Zhang ZX, Dou HD, Hu YH. Genetic epidemiological study on discordant sib pairs of ischemic stroke in Beijing Fangshan District. Journal of Peking University (Health Sciences) 2007;39:119–125. (in Chinese)
    1. Sacco RL, Roberts JK, Jacobs BS. Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology. 1998;17:167–173. doi: 10.1159/000026169.
    1. Flossmann E, Schulz UG, Rothwell PM. Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovasc Dis. 2005;19:1–10. doi: 10.1159/000081905.
    1. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bene J, Melegh B. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry. 2003;74:1615–1620. doi: 10.1136/jnnp.74.12.1615.
    1. Meng Y, Ma Q, Yu Y, Farrell J, Farrer LA, Wilcox MA. Multifactor-dimensionality reduction versus family-based association tests in detecting susceptibility loci in discordant sib-pair studies. BMC Genet. 2005;6:S146. doi: 10.1186/1471-2156-6-S1-S146.
    1. Thorisson GA, Stein LD. The SNP Consortium website: past, present and future. Nucleic Acids Res. 2003;31:124–127. doi: 10.1093/nar/gkg052.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere